B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.57 EUR -3.49% Market Closed
Market Cap: 38.8m EUR

Intrinsic Value

The intrinsic value of one BIOBV stock under the Base Case scenario is 3.86 EUR. Compared to the current market price of 2.57 EUR, Biohit Oyj is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIOBV Intrinsic Value
3.86 EUR
Undervaluation 33%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Biohit Oyj

BIOBV
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BIOBV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Biohit Oyj
OMXH:BIOBV
FI
Health Care
Market Cap
39m EUR
IPO
Jun 18, 1999
FI
Health Care
Market Cap
39m EUR
IPO
Jun 18, 1999
Price
€false
EPS
€false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BIOBV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Biohit Oyj
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biohit Oyj

Current Assets 11m
Cash & Short-Term Investments 6.7m
Receivables 3.2m
Other Current Assets 1.1m
Non-Current Assets 4.6m
Long-Term Investments 139k
PP&E 702k
Intangibles 492k
Other Non-Current Assets 3.2m
Efficiency

Free Cash Flow Analysis
Biohit Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biohit Oyj

Revenue
14.3m EUR
Cost of Revenue
-4.9m EUR
Gross Profit
9.3m EUR
Operating Expenses
-6.8m EUR
Operating Income
2.6m EUR
Other Expenses
11k EUR
Net Income
2.6m EUR
Fundamental Scores

BIOBV Profitability Score
Profitability Due Diligence

Biohit Oyj's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score

Biohit Oyj's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

BIOBV Solvency Score
Solvency Due Diligence

Biohit Oyj's solvency score is 98/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
98/100
Solvency
Score

Biohit Oyj's solvency score is 98/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOBV Price Targets Summary
Biohit Oyj

Wall Street analysts forecast BIOBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOBV is 3.26 EUR with a low forecast of 3.23 EUR and a high forecast of 3.36 EUR.

Lowest
Price Target
3.23 EUR
26% Upside
Average
Price Target
3.26 EUR
27% Upside
Highest
Price Target
3.36 EUR
31% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIOBV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one BIOBV stock?

The intrinsic value of one BIOBV stock under the Base Case scenario is 3.86 EUR.

Is BIOBV stock undervalued or overvalued?

Compared to the current market price of 2.57 EUR, Biohit Oyj is Undervalued by 33%.

Back to Top